Rocky Mountain Chronic Disease Specialis is categorized under Family Practice Doctors in Colorado Springs, CO and active since 2006.
Rocky Mountain Chronic Disease Specialis was established in 2006, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact at the company’s single location by writing to 5710 Harbor Pines Point, Colorado Springs, Colorado CO 80919 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rocky Mountain Chronic Disease Specialis |
| Address: | 5710 Harbor Pines Point, Colorado Springs, Colorado 80919 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Rocky Mountain Chronic Disease Specialis was started in 2006 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact for inquiries that concern Rocky Mountain Chronic Disease Specialis by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Rocky Mountain Chronic Disease Specialis can be found at the coordinates as well as the street address 5710 Harbor Pines Point in Colorado Springs, Colorado 80919.
For its online presence, you may visit Rocky Mountain Chronic Disease Specialis’s website at and engage with its social media outlets through on Twitter and on Facebook.